Skip to main content

Table 4 In silico bioavailability prediction and cLogP value

From: Design, synthesis, ADME prediction and pharmacological evaluation of novel benzimidazole-1,2,3-triazole-sulfonamide hybrids as antimicrobial and antiproliferative agents

Compd. no

In silico Bioavailability and cLogP

Bioavailability score

cLogP

Lipinski

Ghose

Veber

4a

3.19

Yes

No

No

0.55

4b

2.31

Yes

Yes

No

0.55

4c

3.24

Yes

Yes

No

0.55

4d

3.19

Yes

Yes

No

0.55

4e

3.34

Yes

No; 1 violation

No

0.55

4f

1.52

Yes

Yes

No

0.55

6a

4.11

No

No

No

0.17

6b

2.35

No

No

No

0.17

6c

4.20

No

No

No

0.17

6d

4.10

No

No

No

0.17

6e

4.41

No

No

No

0.17

6f

0.75

No

No

No

0.17

Cipro.

− 0.70

Yes

Yes

Yes

0.55

Fluco.

− 0.12

Yes

Yes

Yes

0.55